Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen)
Übersicht


Zum ersten Bild Abb. 30: Telmisartan - HCTZ Abb. 31: Telmisartan - HCTZ Abb. 32: Telmisartan - Losartan - HCTZ Aktuelles Bild - Abb. 33: Telmisartan - Losartan - HCTZ Abb. 34: Telmisartan - Valsartan - HCTZ Abb. 35: Telmisartan - HCTZ Abb. 36: Telmisartan - HCTZ Zum letzten Bild
Abbildung 33: Telmisartan - Losartan - HCTZ
Shown here are the combined data from two 6-week, prospective, randomized, open-label, blinded endpoint (PROBE) study comparing telmisartan 40 mg + HCTZ 12.5 mg (n=485), telmisartan 80 mg + HCTZ 12.5 mg (n=356) and losartan 50 mg + HCTZ 12.5 mg (n=489).1 Control/response rates were defined as follows: DBP control = 24-h mean DBP <85 mmHg DBP response = 24-h mean DBP <85 mmHg or reduction from baseline ≥10 mmHg SBP response = 24-h mean SBP <130 mmHg or reduction from baseline ≥10 mmHg There was a trend towards superiority in DBP control, DBP response and SBP response rates with telmisartan/HCTZ, and telmisartan 80 mg/HCTZ produced significantly greater DBP control and SBP response rates than losartan/HCTZ. 1. Data on file. Boehringer Ingelheim, GmbH.
 
Telmisartan - Losartan - HCTZ
Vorheriges Bild Nächstes Bild   


Abbildung 33: Telmisartan - Losartan - HCTZ
Shown here are the combined data from two 6-week, prospective, randomized, open-label, blinded endpoint (PROBE) study comparing telmisartan 40 mg + HCTZ 12.5 mg (n=485), telmisartan 80 mg + HCTZ 12.5 mg (n=356) and losartan 50 mg + HCTZ 12.5 mg (n=489).1 Control/response rates were defined as follows: DBP control = 24-h mean DBP <85 mmHg DBP response = 24-h mean DBP <85 mmHg or reduction from baseline ≥10 mmHg SBP response = 24-h mean SBP <130 mmHg or reduction from baseline ≥10 mmHg There was a trend towards superiority in DBP control, DBP response and SBP response rates with telmisartan/HCTZ, and telmisartan 80 mg/HCTZ produced significantly greater DBP control and SBP response rates than losartan/HCTZ. 1. Data on file. Boehringer Ingelheim, GmbH.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung